filmov
tv
Biotech executives believe Covid-19 vaccine will be developed, but also expect a second wave: Survey
Показать описание
Mark Dempster, co-head of Stifel Healthcare Group, discusses the firm's new survey of how executives at top biotech companies view the COVID-19 pandemic, and the overall rise in interest by investors in the sector.
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
Biotech executives believe Covid-19 vaccine will be developed, but also expect a second wave: Survey
Biotech and the race to a Covid-19 vaccine
How Moderna And Pfizer-BioNTech Developed Vaccines In Record Time
Adaptive Biotechnologies CEO on Covid-19 research efforts, Russia vaccine claims
The Race for a Covid-19 Vaccine
Looking for a drug to fight the coronavirus outbreak: Vir Biotechnology CEO
Covid could become like the flu, creating opportunities in science: Cantor's Alethia Young
Biotech, Developing & Developed Countries Vaccine Manufacturers COVID-19 Press Briefing - 23 Apr...
Biotech companies need capital, but challenge is finding high quality management teams: Cowen CEO
Novavax CEO Stanley Erck on the company's Covid-19 vaccine
Pfizer CEO on Covid-19 vaccine efficacy: 'It is a great day for humanity'
Coronavirus: VIR CEO on partnering with GSK to develop treatments, vaccines
Biotech, Developing & Developed Countries Vaccine Manufacturers COVID-19 Press Briefing - 16 Dec...
Moderna CEO on kick off of phase three Covid-19 vaccine trial
COVID-19 and the Law: The Use of Biotech in the COVID-19 Pandemic
Biotech Innovation in the Time of COVID-19
With COVID-19 vaccine in Phase 1 trial, Novavax CEO says goal is to make 1B doses
Novavax CEO on the company's phase one Australia Covid-19 vaccine trial
Why Pfizer Is Betting Big On An Unproven Treatment For Covid-19 | Forbes
The Race to Develop Vaccines for COVID-19
Future of Biotech & the Evolving Global COVID Vaccine Landscape -NATHEALTH Thought Leadership Se...
Novavax CEO on $1.6 billion in federal funding, Covid-19 vaccine progress and more
Vancouver biotech company's drug in clinical trial for COVID-19
Sanofi CEO Paul Hudson on COVID-19 and potential vaccine (Full Stream 11/10)
Комментарии